Subgroup analysis of the lipid infusion and patient outcomes in sepsis trial (LIPOS) reveals benefit in a subgroup not treated with stress replacement doses of corticosteroids
Crossref DOI link: https://doi.org/10.1186/cc14065
Published Online: 2014-12-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Parker, TS
Levine, DM
Gordon, BR
Saal, SD
Text and Data Mining valid from 2014-12-03
Version of Record valid from 2014-12-03
Article History
First Online: 3 December 2014